Friday, 24 September 2021 16:00 CEST


David Hildick-Smith, Brighton and Sussex University Hospital, Brighton, UK

John Thomson, Johns Hopkins University, Baltimore, USA


Q&A moderator:

Bushra Rana, Imperial College Healthcare Trust, London, UK



Horst Sievert, CardioVascular Center Frankfurt CVC, Frankfurt, Germany

Brian Clapp, Guy's and St. Thomas' NHS Foundation Trust, London, UK

Niki Walker, Golden Jubilee National Hospital, Clydebank, Scotland

Julian Widder, Hannover Medical School, Hannover, Germany

Ada Stefanescu, Massachusetts General Hospital, Harvard Medical School, Boston, USA

Mark Turner, University Hospitals Bristol NHS Foundation Trust, Bristol, UK

Bernhard Meier, University Hospital of Bern, Bern, Switzerland


The optimal “device”, given what we know currently, what is needed? >> Horst Sievert

Amplatzer-strengths and weaknesses >> Brian Clapp

Cardioform-strengths and weaknesses >> Niki Walker

Occlutech-strengths and weaknesses >> Julian Widder

AF testing pre-implant - what’s reasonable, what is evidence based? >> Ada Stefanescu

AF post implant - irritant or genuine problem? >> Mark Turner

Going beyond the RCTs, evidence for closure in:

  • ​Older patients >> David Hildick-Smith
  • "Non brain/cerebral” emboli >> Bernhard Meier


The webinar is accredited by the European Board for Accreditation in Continuing Education for Health Professionals (EBAC) for a maximum of 2 European CME credits (ECMEC®s) and is accredited by the Landesärtzekammer Hessen for 2 CME credits.

Through an agreement between the European Board for Accreditation in Cardiology and the American Medical Association, physicians may convert EBAC External CME credits to AMA PRA Category 1 Credits™. Information on the process to convert EBAC credit to AMA credit can be found on the AMA website




This webinar is supported by: